Pageflex Server [Document: D-3735B84E 00001]
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
23 April 2020 Update
20 April – 23 April 2020 Contents I. Summary .............................................................................................................................1 II. European Union .................................................................................................................5 III. France ...............................................................................................................................6 IV. Italy ...................................................................................................................................7 V. Germany ............................................................................................................................8 VI. Spain ...............................................................................................................................10 VII. United Kingdom .............................................................................................................10 I. SUMMARY Number of cases: 1,009,762 (including the UK) Number of deaths: 108,223 • The EU Executive Steering Group on Shortages of Medicines Caused by Major Events held a meeting on 15 April to discuss the progress of the measures regarding availability of medicines for European patients during the COVID-19 pandemic. They also updated the Q&A document on regulatory expectations for medicinal products for human use during the COVID-19 pandemic on 20 April. On 21 April, they set-up the fast-track system to support essential medicines for COVID-19 treatment, -
Written Evidence from Spotlight on Corruption1 (PGG18) the Public
Written evidence from Spotlight on Corruption1 (PGG18) The Public Administration and Constitutional Affairs Committee Propriety of governance in light of Greensill inquiry Introduction The revelations arising from the Greensill affair and its fallout, coming alongside other recent and ongoing scandals, have exposed significant weaknesses in the UK system for managing conflicts of interest, lobbying, and business appointments. This is a vital opportunity to bring the UK’s standards landscape up to date, and to ensure that integrity and ethics in government are regulated in a way that befits a modern democracy. Taking action to strengthen the UK’s integrity and ethics framework would benefit the UK by helping to: build trust in politicians and government; strengthen the stability, predictability and attractiveness of the UK as a place to do business; give the UK greater credibility on the international stage in promoting democracy and good governance; and implement outstanding recommendations made by international bodies such as the UN and Council of Europe about how the UK can improve its integrity and ethics framework to prevent and tackle corruption. Key Recommendations 1. Integrity and Ethics legislation. The government should consult on the introduction of an Integrity and Ethics Bill, by the spring of 2022, which gives legislative effect to: the Law Commission’s recommendations on the introduction of a corruption in public office offence; recommendations made by international bodies to put ACOBA and the Independent Advisor on Ministerial Interests on a statutory footing; recommendations that are likely to be made by the Committee on Standards in Public Life’s Standards Matters 2.0 review in the Autumn of 2021; and recommendations likely to be made from both the Boardman review and parliamentary committees such as PACAC, including legislative reform to the Lobbying Act. -
The NHS Is a Health System Not a Charity. It Should Be Funded Accordingly, Writes Rebecca Richards
The NHS is a health system not a charity. It should be funded accordingly, writes Rebecca Richards He walked his way into the hearts of a nation – one lap of his garden at a time. In doing so, 100-year-old – soon to be Sir – Captain Tom Moore raised a staggering £29million for the NHS.[1] While perhaps the most publicised, he is not the only private citizen helping the NHS respond to the Covid-19 pandemic. The ‘Run for Heroes’ Challenge – whereby social media users run 5km, donate £5, and nominate five of their friends to do the same – has raised more than £5million in less than a month.[2] And all over the country, people are sewing Personal Protective Equipment (PPE) for frontline healthcare workers that are lacking adequate safety equipment.[3] But the heart-warming response these extraordinary feats of solidarity and good-will elicit in us can also obscure the fact that the NHS should not need this level of support. As an anonymous NHS doctor recently pointed out, ‘The NHS is not a charity’.[4] The NHS is a healthcare system. It is therefore the government’s responsibility to fund, staff, and supply it so that it can effectively respond to a pandemic that was not entirely unexpected.[5] [6] It is a responsibility the government has arguably failed to fulfill adequately. Though not alone in its enforcement of austerity measures over the past decades, [7] the government’s economic policies left the NHS under pressure even before the pandemic broke out.[8] Between 2010 and 2014, for example, the real-term annual increase in NHS England funding was only 1.3%, down from historical annual growth rates of approximately 4%.[9] This has been associated with nearly 120,000 preventable deaths in England during this time period.[10] And though the government committed to increasing NHS funding in 2018,[11] this – and subsequent government funding increases – has not been enough to ‘reverse years of health underfunding’.[12] When the magnitude of the Covid-19 crisis became clear, the NHS was therefore not fully prepared. -
UK COVID-19 Vaccines Delivery Plan
UK COVID-19 vaccines delivery plan Published 11 January 2021 Contents 1. Ministerial foreword ....................................................................................................... 3 2. Executive summary and scope ..................................................................................... 4 Supply .............................................................................................................................. 5 Prioritisation ...................................................................................................................... 6 Places ............................................................................................................................... 7 People .............................................................................................................................. 8 Tracking our progress ....................................................................................................... 9 3. Supply ......................................................................................................................... 10 Developing new vaccines ............................................................................................... 10 Ensuring vaccines meet strict safety standards for deployment ..................................... 17 Building UK manufacturing capability ............................................................................. 21 4. Prioritisation ............................................................................................................... -
COVID-19 Interim Vaccination Plan V.5 Pennsylvania
COVID-19 Interim Vaccination Plan V.5 Pennsylvania PA COVID-19 Vaccine Task Force/PA Department of Health JANUARY 19, 2021 |VERSION 5.0 PENNSYLVANIA COVID-19 INTERIM VACCINATION PLAN Table of Contents Introduction……………………………………………………………………………………………………………………………………….2 Section 1: COVID-19 Vaccination Preparedness Planning ......................................................................... 3 Section 2: COVID-19 Organizational Structure and Partner Involvement ................................................. 4 Section 3: Phased Approach to COVID-19 Vaccination ........................................................................... 11 Section 4: Critical Populations ................................................................................................................. 17 Section 5: COVID-19 Provider Recruitment and Enrollment ................................................................... 21 Section 6: COVID-19 Vaccine Administration Capacity ........................................................................... 25 1. Health and Medical Infrastructure .......................................................................................... 25 2. Occupational Health Clinics and Closed Points of Dispensing (PODs) ..................................... 26 3. Expanded Outreach to Ensure Vaccine Access ........................................................................ 27 4. Staffing .................................................................................................................................... -
Role and Responsibilities of the Chair of the Vaccine Taskforce
Chair of the Vaccine Taskforce Information pack for applicants Closing date: Midday on Friday 14 May 2021 Reference no: VAC-1775 Follow us on Twitter @appointmentsdh Table of Contents Section 1: Role, responsibilities and person specification.................................................... 2 Section 2: How to apply ....................................................................................................... 4 2.1 Making an application ............................................................................................. 4 2.2 The selection process ............................................................................................. 7 2.3 Eligibility criteria ...................................................................................................... 9 2.4 How we will manage your personal information .................................................... 10 Chair of the Vaccine Taskforce - Information pack for applicants Section 1: Role and responsibilities of the Chair of the Vaccine Taskforce The Chair must enable the Vaccine Taskforce to achieve their three core objectives during the pandemic period: a. To secure access to promising vaccine/s for the UK population. b. To make provision for international distribution of vaccines. c. To strengthen the UK’s onshore capacity and capability in vaccine development, manufacturing, and supply chain to provide resilience for this and future pandemics. In recognising that the Taskforce has now been in existence for over a year, delivering these objectives -
Captain Tom Moore
Captain Tom Moore Captain Tom Moore is the war veteran who made headlines around the world in mid-April 2020, when he pledged to raise money for the National Health Service (NHS), by walking 100 laps around his garden before his 100th birthday on April 30th. The Challenge Captain Tom has long been a supporter of the NHS. He spent some time in hospital after a hip replacement a few years ago and has been following the news about the NHS, who have been working hard to treat patients during the COVID-19 crisis. He decided to set himself the challenge of completing 100 laps of his 25 metre garden, walking 10 laps each day, finishing before his 100th birthday. Captain Tom hoped to raise £1000 for NHS Charities Together. Worldwide Support Captain Tom’s challenge was reported by his local news and word soon spread about his amazing effort. People very quickly took Captain Tom to their hearts and his story was shared more widely, including on the national news. More and more people donated money from all over the world. Within a day, Captain Tom had exceeded his target. Captain Tom completed his 100 laps two weeks before his birthday, so decided to increase the number of laps he walked to 200. More Fundraising To help celebrate Tom reaching 100 laps, singer Michael Ball, the NHS Voices of Care Choir and Captain Tom released a version of the song ‘You’ll Never Walk Alone’, which was number one in the singles charts on 24th April. Captain Tom is the oldest person ever to reach number one and the single is the fastest selling of 2020 so far. -
WHO Backs Rollout of Astrazeneca Vaccine
this week TWINS page 423 • VACCINATING CHILDREN page 424 • BRITISH CYCLING page 427 FRANK HOERMANN/DPA/PA/ALAMY FRANK WHO backs rollout of AstraZeneca vaccine Doctors have warned of the risks associated On 16 March WHO’s chief scientist, Soumya The World Health Organization with pausing or delaying vaccination Swaminathan, said, “We do not want has urged people not to panic programmes against covid-19, as the people to panic, and we would, for the time amid reports of blood clotting number of European countries that have being, recommend that countries continue disorders in patients receiving the vaccine halted use of the Oxford University and vaccinating with AstraZeneca . So far, we AstraZeneca vaccine rose to 16. do not fi nd an association between these Denmark, Norway, Bulgaria, Iceland, events and the vaccine.” France, Germany, Italy, Spain, Portugal, The EMA said there had been 30 reports Slovenia, and Cyprus have suspended all of thromboembolic events among nearly use of the vaccine. Five other countries fi ve million people given the AstraZeneca (Austria, Estonia, Latvia, Lithuania, and vaccine in the European Economic Area. Luxembourg) have paused the use of a AstraZeneca has said 37 blood clots have LATEST ONLINE batch of a million doses of the vaccine. been reported among more than 17 million NHS and social The moves came after reports of people vaccinated in the EU and Britain. care need an extra blood clotting disorders. The Norwegian Five of the cases were deep vein thrombosis, £12bn to get back Medicines Agency said last week it was and 22 were pulmonary embolisms. -
UKC Monthly Summary 2020 July.Odt
UK COLUMN CONTENT – July 2020 https://www.ukcolumn.org/ukcolumn-news-archive 01st July 2020 Brian Gerrish and Mike Robinson with today's UK Column News. START – Good news: excess mortality rate falls below five-year average Leicester local lockdown – police to spot-check cars leaving the restricted zone… Government provides details without showing any evidence to support them SAGE recommended ramping up fear and turning communities against each other The Ferguson effect: a similar situation occurred with Foot & Mouth – community division This policy seems deliberate by the UK ‘government of occupation’ Increased Covid-19 testing will obviously result in an increase in reported cases Is this a trial run and normalisation of ‘City State’ powers…? CoronaVirus found in waste water as early as March 2019 in Spain The spike in excess deaths across the world happened after lockdown… 15:49 – More fear: schools, hospitals and offices told to prepare for ‘marauding’ terror attacks Mail Online: is your teen secretly struggling with depression…? Mail Online: workers’ health starts to fail at the age of 59 MSM complains about Covid-19 infodemic – the ‘wrong’ kind of information… 19:28 – David Noakes (GcMAF) contact information CoronaVirus: Upper Crust owner blames lockdown for 5,000 UK redundancies Michael Gove quotes Franklin Delano Roosevelt in Brexit comments Gove suggests that change is coming to the UK Civil Service Boris announces a ‘new deal’ - ‘the opportunity is massive’ The MainStream Media reaction to Boris…? Nothing, silence… MSM too busy -
MCC VA COVID-19 Vaccine Provider FAQ May 2021
COVID-19 Vaccine Provider FAQs We are actively monitoring COVID-19 vaccine developments. Below you will find helpful information and answers to some of the most frequently asked questions about COVID-19 vaccines. Magellan Complete Care has a COVID-19 Vaccine Taskforce comprised of experts, including clinicians, health plan leadership, and pharmacy network team members that meets regularly to discuss the latest developments and plan support. We are monitoring government guidance at the federal and state levels. We are taking steps to ensure you have the information you need as the information and guidelines are made available by federal and state agencies. Vaccine Development and Distribution Operation Warp Speed (OWS) was set up by the White House to coordinate efforts among federal government entities, states, and private sector partners. It aims to accelerate the testing, supply, development, and distribution of safe and effective vaccines, therapeutics, and diagnostics. There are many government agencies involved in helping with the COVID-19 pandemic. A few of the key agencies are listed below for your reference: • Food and Drug Administration (FDA) – The FDA reviews and approves or authorizes safe and effective vaccines. • Centers for Disease Control and Prevention (CDC) – The CDC is responsible for controlling the introduction and spread of infectious diseases. • Advisory Committee on Immunization Practices (ACIP) – ACIP is a committee within the CDC that provides advice and guidance on effective control of vaccine-preventable diseases in the U.S. civilian population. • National Academies of Science Engineering & Medicine (NASEM) – The National Institutes of Health (NIH) and CDC have tasked NASEM to develop a plan for equitable allocation of vaccines. -
Festival Review 2020
1666 PARTWWW.FESTIVALOFGOVERNANCE.ORG 2 Restoration and recovery with hindsight from the Great Fire of London 50 Robert Hooke, surveyor to the City of London and curator of experiments for the Royal Society, stalked up the ruins of Fish 270320 Street Hill to his next appointment. He picked 27 March 2020 his way down roads that were more like the ghosts of roads, marked out in wooden stakes, • Global Deaths just over 27,000, cases 593,291 passing lots covered in tumbled bricks and • UK deaths 181 today (biggest daily total), cases scorched timbers and lean-tos occupied by approach 15,000 families squatting on the sites of their former • Boris Johnson anD Matt Hancock both announce they homes. Four years after September 1666, when have COVID-19 the Great Fire of London had destroyed one • Italy Death toll toDay 919 (total 9,134), cases 86,000 quarter of the quickly-growing city, the land still • UK doctors set up crowdfund for PPE smelled like the chimney of a great hearth. The sound of hammers and labourers’ grunts was the soundtrack to his walk, and as he passed crews of carpenters and masons, site overseers invariably nodded their greetings. So many of the people Hooke passed knew this whip-thin man with a curved back and outsized forehead, who looked frail and bookish but stepped lively. He carried a satchel of instruments, record books and stakes. After 20 minutes’ brisk walk Hooke reached his goal: the ruins of a cooper’s workshop and house. Before the f re, it was likely a timbered house whose upper storey had probably perched over the street so far it blocked the sun. -
Annex a – Analysis
ANNEX A - ANALYSIS ANNEX A – ANALYSIS FULL ANALYSIS OF WEST WALES AND THE VALLEYS AREA OVERVIEW 1.1 West Wales and the Valleys covers an area of 1.24 million hectares (around 12,400 km2) with approximately 1,150 km of coastline. Approximately 80% of the total area of West Wales and the Valleys is designated as Less Favourable Areas, which parallels closely the mountainous and upland areas. West Wales and the Valleys is a diverse area of Wales comprising a population of some 1.86 million (64% of the total population of Wales). The area includes the following local authorities: • Isle of Anglesey; • Gwynedd; • Conwy; • Denbighshire; • Ceredigion; • Pembrokeshire; • Carmarthenshire; • Swansea; • Neath Port Talbot; • Bridgend; • Rhondda, Cynon, Taff; • Merthyr Tydfil; • Caerphilly; • Blaenau Gwent; and • Torfaen. 1 ANNEX A - ANALYSIS Figure 1. Map of the West Wales and the Valleys Convergence Programmes area 2 ANNEX A - ANALYSIS 1.2 The following sections provide an overview of the socio, demographic, economic and environmental conditions across West Wales and the Valleys, and highlight areas where West Wales and the Valleys varies from Wales, the UK and the European Union as a whole using statistics from the Office for National Statistics, the Welsh Assembly Government and Eurostat (in particular the Regio database). 1.3 Table 1 below shows the population of West Wales and the Valleys by local authority according to the proportion of the total population living in the West Wales and the Valleys. As Table 1 shows, over 60% of the population of West Wales and the Valleys is concentrated in the South Wales Valleys.